Corticosteroid co-medication does not reduce the incidence and severity of neurotoxicity induced by docetaxel. [electronic resource]
Producer: 19990212Description: 759-64 p. digitalISSN:- 0959-4973
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- adverse effects
- Breast Neoplasms -- drug therapy
- Dexamethasone -- therapeutic use
- Docetaxel
- Female
- Glucocorticoids -- therapeutic use
- Humans
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Nervous System Diseases -- chemically induced
- Paclitaxel -- adverse effects
- Prospective Studies
- Taxoids
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.